Detalles de la búsqueda
1.
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.
Ann Hematol
; 103(4): 1139-1147, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296903
2.
Trajectories of health-related quality of life among renal transplant patients associated with graft failure and symptom distress: Analysis of the BENEFIT and BENEFIT-EXT trials.
Am J Transplant
; 20(6): 1650-1658, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31874117
3.
Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis.
Clin Exp Rheumatol
; 38(3): 455-466, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770089
4.
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.
Rheumatol Int
; 40(8): 1239-1248, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449040
5.
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study.
Ann Intern Med
; 170(12): 825-836, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31108503
6.
Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis.
Value Health
; 21(2): 193-202, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477401
7.
Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.
Rheumatology (Oxford)
; 56(5): 777-786, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087832
8.
Cardiovascular risk factor management in patients with RA compared to matched non-RA patients.
Rheumatology (Oxford)
; 55(5): 809-16, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26705329
9.
Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus.
Lupus
; 29(6): 625-630, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32188304
10.
Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis.
Ther Adv Musculoskelet Dis
; 13: 1759720X211002682, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33854570
11.
Evaluation of the Effect of Diabetes on Rheumatoid Arthritis-related Outcomes in an Electronic Health Record-based Rheumatology Registry.
J Rheumatol
; 48(7): 992-1001, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262304
12.
Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease-Modifying Antirheumatic Drugs: Results From a Real-World Study.
Arthritis Care Res (Hoboken)
; 72(2): 176-183, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31529682
13.
Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus.
ACR Open Rheumatol
; 2(1): 53-60, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943975
14.
Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis.
Curr Med Res Opin
; 36(2): 337-342, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31612736
15.
Prevalence of Sjögren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry.
Clin Rheumatol
; 39(6): 1899-1905, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32130579
16.
Association of Changes in Anticitrullinated Protein Antibody Levels With Resource Use and Disease Activity Measures in Rheumatoid Arthritis Patients a US Observational Cohort.
Clin Ther
; 41(6): 1057-1065.e3, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31130229
17.
Economic Evaluation of Anticyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis.
J Manag Care Spec Pharm
; 25(4): 469-477, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917075
18.
Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry.
Rheumatol Ther
; 6(2): 217-230, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30868550
19.
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
Arthritis Res Ther
; 21(1): 138, 2019 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171024
20.
Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE).
Rheumatol Ther
; 6(4): 559-571, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31642045